Trial Profile
A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Adverse reactions
- Sponsors Ildong Pharmaceutical
- 04 Sep 2018 New trial record